Physician profile
William H Rawls
NPI 1639157753
$4,342.67
in general payments reported to CMS, 2019-2025
20 companies · $681 in 2025
The $681 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $63.82 · 2021: $218 · 2022: $472 · 2023: $1,561 · 2024: $869 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,034 · Travel and Lodging: $952 · Grant: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,034.05 |
| Travel and Lodging | $951.76 |
| Grant | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $1,829.93 | 2021-2023 | |
| Bioprotect Medical, INC. | $771.64 | 2024-2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $264.63 | 2019-2022 | |
| Janssen Biotech, INC. | $262.23 | 2022-2024 | Erleada |
| Procept Biorobotics Corporation | $198.88 | 2025 | |
| Teleflex LLC | $190.84 | 2022-2024 | |
| Abbvie INC. | $125.00 | 2024 | |
| Astellas Pharma US INC | $105.32 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $104.89 | 2025 | Gemtesa |
| Neotract INC. | $87.97 | 2019 | |
| Pfizer INC. | $76.68 | 2019-2024 | |
| Olympus America INC. | $62.44 | 2019-2020 | |
| Civatech Oncology, INC. | $55.18 | 2019 | |
| Blue Earth Diagnostics | $49.58 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.50 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $42.27 | 2019 | |
| Urovant Sciences INC | $20.08 | 2022 | |
| Cook Medical LLC | $17.80 | 2024 | Litho 150 |
| Merck Sharp & Dohme LLC | $16.06 | 2019 | |
| Photocure INC | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Rawls listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.